Piramal Pharma shares rose 13.5 percent in early trade on May 25, as investors cheered the drugmaker's strong earnings recovery in the fiscal quarter ended March 31, 2023. During the fourth quarter of FY23, the company achieved its highest margins...
Indian-manufactured cough syrups, India has made the testing of cough syrups before to export mandatory as of June 1. The Drugs Controller General of India (DCGI) has directed that such samples from manufacturers be examined "as soon as possible" ...
Highlighting that the Government of India has taken initiatives for value-based healthcare supported by health workforce mobility and patient mobility, Dr Mansukh Mandaviya, Union Minister of Health and Family Welfare, said on Wednesday,...
As per the sources in a medical journal, Pfizer Inc's diabetes drug resulted in weight loss comparable to Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabetes...
Venus Remedies announced this week it has received good manufacturing practises (GMP) accreditation from Kenya for all of its production facilities in Baddi, Himachal Pradesh. According to a corporate release, the certification was obtained....
SKAN Research Trust, promoted by Indian entrepreneur Mr. Ashok Soota and UK-based Quadram Institute Bioscience have entered into a Comprehensive Partnership Agreement to collaborate on research programmes focused on gut health and developing...
Granules India, a Rs. 4,500 crore pharma major, has posted single digit growth in consolidated net profit during the fourth quarter ended March 2023 to Rs. 120 crore from Rs. 111 crore in the corresponding quarter of last year. Its revenues...
Hepion Pharmaceuticals Inc said yesterday its treatment met the main goal of improving liver function in patients with a type of fatty liver disease in a mid-stage study trial, sending its shares 45 per cent higher in premarket trading...
Genetic testing allows doctors to tailor treatments to individual patients, making them more effective and reducing side effects. Genetic testing also enables doctors to provide more accurate diagnoses.
Amyris, Inc., a leading synthetic biotechnology company, announced that it has signed an exclusive licence agreement for the supply of sustainable squalene with British specialty chemicals company Croda International Plc (Croda)...
, CDSCO.jpg)
